Using magnetic pulses to treat impulsivity and suicidal thoughts in veterans with mild brain injuries
Official title: Neuromodulation for Impulsivity and Suicidality in Veterans With Mild Traumatic Brain Injury and Common Co-occurring Mental Health Conditions
Run by VA Office of Research and Development · NCT05647044 · Data updated 2026-11-12
This study is testing if a new treatment using magnetic pulses can help veterans with mild brain injuries reduce impulsivity and suicidal thoughts.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 22 Years to 65 Years |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Hines, Illinois) |
| Status | Recruiting |
| Started | May 20, 2024 |
| Main results expected | March 31, 2028 |
| Study ends | March 31, 2028 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT05647044 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are veterans aged 22-65 who have experienced mild traumatic brain injury and exhibit impulsivity and suicidal ideation.
✕Probably not a fit
Patients with a history of moderate to severe traumatic brain injury or those with contraindications to iTBS or MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the safety and effectiveness of intermittent theta burst stimulation (iTBS) in treating impulsivity and suicidal ideation in veterans who have experienced mild traumatic brain injury (mTBI). The approach involves applying high-powered magnetic pulses to the front of the head to activate brain cells and strengthen connections that may help alleviate these symptoms. Participants will be assessed for their impulsivity and suicidal thoughts, and the data collected will inform future larger studies. The study is particularly significant as there are currently no effective treatments for these co-occurring conditions in this population.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce impulsivity and suicidal thoughts in veterans with mild traumatic brain injuries.
How similar studies have gone: While transcranial magnetic stimulation has shown promise in treating various conditions, this specific application for impulsivity and suicidal ideation in veterans with mTBI is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 22-65 years of age * can read and speak English * meets criteria for mTBI according to the symptom attribution and classification (SACA) scale * Has a C-SSRS (suicidal ideation rating) of \>1 within the past month * Has a history of impulsivity documented in the medical chart and/or a score of \>20 on the UPPS-P negative urgency impulsivity subscale Exclusion Criteria: * Has contraindications to iTBS (i.e., epilepsy) * Has contraindications to MRI (i.e., claustrophobia, ferromagnetic metal implants) * Has an active substance use disorder per the DSM-V criteria * Has a history of moderate to severe TBI * Has a history of non-traumatic neuroinjury (i.e., stroke, neurosurgery, hemorrhage) * Has a history of, or current psychosis not due to an external cause * Is pregnant * Has an active, unstable medical condition * Is within 12 weeks of a major surgery or operation * Is within 1 year of TBI
Where it's running
-
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States Recruiting
Study contacts
- Principal investigator: Alexandra L Aaronson, MD — Edward Hines Jr. VA Hospital, Hines, IL
- Study coordinator: Alexandra L Aaronson, MD
- Email: Alexandra.Aaronson@va.gov
- Phone: (708) 202-8387
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department
This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
-
Student Precarity and Psychiatry: How Financial Struggles Relate to Depression and Loneliness
This observational study looks at whether financial hardship and social isolation are linked to depression, suicidal thoughts, and loneliness among French university students.
-
Intensive neurofeedback for children with ADHD: personalized vs. standard theta-beta training
This study tests two neurofeedback approaches in children with ADHD to see if a personalized, iAPF-based theta-beta training works better than a standard theta-beta training.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.